Change of opinion on the use of hydroxychloroquine for COVID-19 treatment and prevention by K. B. Mirzaev, D. A. Sychev

Get full text

Current and future use of remdesivir in patients with COVID-19 by V. M. Tsvetov, K. B. Mirzaev, D. A. Sychev

Get full text

Comparative clinical and economic evaluation of pharmacogenetic testing application for dabigatran in patients with atrial fibrillation by Sh P Abdullaev, K B Mirzaev, D A Sychev

Get full text

Methylprednisolone in acute respiratory distress-syndrome in COVID-19: rationales for use, optimal dosage regimens, combined use with tocilizumab by K. B. Mirzaev, Yu. Yu. Kiselev, D. A. Sychev

Get full text

EVALUATION OF PLATELET AGGREGATION IN CLINICAL PRACTICE by K. B. Mirzaev, D. A. Andreev, D. A. Sychev

Get full text

EVALUATION OF PLATELET AGGREGATION IN CLINICAL PRACTICE by K. B. Mirzaev, D. A. Andreev, D. A. Sychev

Get full text

Could canakinumab be used for COVID-19? by V. A. Otdelenov, K. B. Mirzaev, D. A. Sychev

Get full text

Possibility for the use of bromhexine to prevent infection with SARS-CoV-2 by K. A. Zagorodnikova, K. B. Mirzaev, D. A. Sychev

Get full text

Possibility to use direct oral anticoagulants to prevent thromboembolic events in patients with COVID-19 by V. A. Otdelenov, K. B. Mirzaev, D. A. Sychev

Get full text

Dexamethasone use in patients with COVID-19 by V. A. Otdelenov, K. B. Mirzaev, D. A. Sychev

Get full text

GENETICS OF CLOPIDOGREL RESISTANCE: RECENT DATA by K. B. Mirzaev, D. A. Sychev, D. A. Andreev

Get full text

Is it possible to use riamilovir to prevent infection and treat COVID-19? by V. M. Tsvetov, K. B. Mirzaev, D. A. Sychev

Get full text

Can inhalations of hyaluronidase be used in acute respiratory distress-syndrome in patients with COVID-19? by Yu. Yu. Kiselev, K. B. Mirzaev, D. A. Sychev

Get full text

Current and future use of dipyridamole in patients with COVID-19 by I. S. Burashnikova, V. M. Tsvetov, K. B. Mirzaev, D. A. Sychev

Get full text

Multi-Ethnic Analysis of Cardiac Pharmacogenetic Markers of Cytochrome P450 and Membrane Transporters Genes in the Russian Population by K. B. Mirzaev, D. S. Fedorinov, D. V. Ivashchenko, D. A. Sychev

Get full text

Micro-RNA as a new biomarker of activity of the cytochrome system P-450: significance for predicting the antiplatelet action of P2Y12 receptor inhibitors by E I Rytkin, K B Mirzaev, I V Bure, D A Sychev

Get full text

Current and future use of aminodihydrophthalazindione sodium in patients with COVID-19, including for «cytokine storm» therapy by V. M. Tsvetov, Yu. Yu. Kiselev, K. B. Mirzaev, D. A. Sychev

Get full text

What are the indications for combined use of hydroxychloroquine and lopinavir/ritonavir, and how should treatment safety monitoring be performed? by Yu. Yu. Kiselev, V. M. Tsvetov, K. B. Mirzaev, D. A. Sychev

Get full text

THE SIGNIFICANCE OF PHARMACOGENETIC CYP2C19 TESTING FOR PERSONALIZATION OF THE ANTIPLATELET THERAPY IN CARDIOLOGY PRACTICE by K. B. Mirzaev, D. A. Sychev, D. A. Andreev, A. B. Prokofiev

Get full text

THE SIGNIFICANCE OF PHARMACOGENETIC CYP2C19 TESTING FOR PERSONALIZATION OF THE ANTIPLATELET THERAPY IN CARDIOLOGY PRACTICE by K. B. Mirzaev, D. A. Sychev, D. A. Andreev, A. B. Prokofiev

Get full text